Zalewski, D* Dotaz Zobrazit nápovědu
203 s. : il.
838 s. : il.
- Konspekt
- Lékařské vědy. Lékařství
- NLK Obory
- pediatrie
- gastroenterologie
- MeSH
- lidé MeSH
- pankreatitida chirurgie MeSH
- pooperační komplikace MeSH
- Check Tag
- lidé MeSH
The study aimed to determine the content of selenium (Se), zinc (Zn), copper (Cu) and cadmium (Cd) in the liver of predominantly plant-eating omnivore wild boar (Sus scrofa), predominantly meat-eating omnivore red fox (Vulpes vulpes) and herbivore red deer (Cervus elaphus), from North-Eastern Poland (Warmia and Mazury), in order to verify the distribution of these elements in the trophic pyramid. Furthermore, the study was used to assess the risk of eating venison. Samples were analyzed using atomic absorption spectrophotometry. The average concentration of Se was 3.9 (p⟨0.001) and 1.8-fold higher (p0.001) in the wild boar and red fox, respectively, in comparison to the red deer, and 2.1-fold higher in the wild boar comparing to the red fox (p⟨0.001). There was no difference in the average concentration of Zn. The average concentration of Cu was 9.3. Concentration of this element was 5.4-fold higher in red deer in comparison to red fox (p⟨0.001) and 9,34-fold higher than in wild boar (p⟨0.001). The average concentration of Cd was 1.9-fold higher in wild boar in comparison to the red fox (p⟨0.029). Correlation between Cu and Cd concentrations was also observed in the case of the red deer and red fox, while no such correlations were observed between the tested elements in the wild boar. In conclusion, the liver concentrations of these heavy metals in selected wild animas species from the hunting areas of Warmia and Mazury, do not exceed standard safe values for consumers. Moreover, the wild red deer population in North-Eastern Poland is significantly Se deficient.
- MeSH
- játra chemie MeSH
- lišky * MeSH
- Sus scrofa * MeSH
- těžké kovy chemie MeSH
- vysoká zvěř * MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
- Geografické názvy
- Polsko MeSH
Otolaryngologia polska. 20, ISSN 0030-6657 Suplement Tom 49
505 s. : il. ; 26 cm
- MeSH
- otorinolaryngologické nádory MeSH
- Publikační typ
- kongresy MeSH
- Konspekt
- Patologie. Klinická medicína
- NLK Obory
- otorinolaryngologie
- onkologie
Cryptomonadales have acquired their plastids by secondary endosymbiosis. A novel clade-CRY1-has been discovered at the base of the Cryptomonadales tree, but it remains unknown whether it contains plastids. Cryptomonadales are also an important component of phytoplankton assemblages. However, they cannot be readily identified in fixed samples, and knowledge on dynamics and distribution of specific taxa is scarce. We investigated the phenology of the CRY1 lineage, three cryptomonadales clades and a species Proteomonas sulcata in a brackish lagoon of the Baltic Sea (salinity 0.3-3.9) using fluorescence in situ hybridization. A newly design probe revealed that specimens of the CRY1 lineage were aplastidic. This adds evidence against the chromalveolate hypothesis, and suggests that the evolution of cryptomonadales' plastids might have been shorter than is currently assumed. The CRY1 lineage was the most abundant cryptomonad clade in the lagoon. All of the studied cryptomonads peaked in spring at the most freshwater station, except for P. sulcata that peaked in summer and autumn. Salinity and concentration of dissolved inorganic nitrogen most significantly affected their distribution and dynamics. Our findings contribute to the ecology and evolution of cryptomonads, and may advance understanding of evolutionary relationships within the eukaryotic tree of life.
- MeSH
- Cryptophyta cytologie fyziologie MeSH
- plastidy fyziologie MeSH
- salinita * MeSH
- zvláštnosti životní historie * MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Polsko MeSH
OBJECTIVE: To investigate differences and similarities in the clinical approach of young clinicians managing women with endometrial cancer (EC) conservatively. METHODS: A web-based survey was carried out. A platform of the European Network of Young Gynaecological Oncologists (ENYGO) database was used. A 38-item multiple-choice questionnaire was used to evaluate current practice in fertility-sparing management of EC. The survey covered investigations, treatment options, follow-up and management of recurrence and future family planning. Descriptive statistics were used. RESULTS: Overall, 116 out of 650 (17.84%) ENYGO members responded to the survey. In 92 (79.3%) centres, the caseload of early stage EC treated conservatively was less than 10 per year. One hundred and seven responders (93.8%) believe that treatment with progestins could be offered in grade 1 EC without myometrial invasion, but a minority would recommend it even for grade 2 tumours with no myometrial invasion or grade 1 with superficial invasion. The diagnostic tool for establishing grade of tumour was hysteroscopy with dilatation and curettage in 64 (55%) centres. Medroxyprogesterone acetate represents the most commonly prescribed progestogen (55, 47.4%). In 78 (67.2%) centres, a repeat endometrial biopsy was offered after 3 months of treatment commencement. Recurrences are treated mostly with hysterectomy (81, 69.9%) with only a small number of responders recommending to repeat progestin treatment. Lynch syndrome is a contraindication for conservative management in half of the responders (57, 49.1%). Most clinicians agree that patients should be referred promptly for assisted reproductive techniques once complete response has been achieved (68, 58.6%). CONCLUSIONS: Our study shows that conservative management is increasingly offered to women affected by early stage EC wishing to preserve their fertility. Further studies and joint registries are required to evaluate safety and effectiveness of this approach in this probably growing number of patients.
- MeSH
- antitumorózní látky hormonální terapeutické užití MeSH
- asistovaná reprodukce MeSH
- dilatace a kyretáž MeSH
- dospělí MeSH
- endometrium patologie MeSH
- hysteroskopie MeSH
- konzervativní terapie metody MeSH
- lidé MeSH
- lokální recidiva nádoru patologie terapie MeSH
- medroxyprogesteronacetát terapeutické užití MeSH
- myometrium patologie MeSH
- nádory endometria farmakoterapie patologie MeSH
- progestiny terapeutické užití MeSH
- retrospektivní studie MeSH
- těhotenství MeSH
- výsledek terapie MeSH
- zachování plodnosti MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa MeSH